Wisdom Pharmaceuticals (300149.SZ) released its performance for the first half of the year, turning losses into profits of 25.38 million yuan.

Zhitong Finance APP News, Wisdom Pharmaceuticals (300149.SZ) released its semi-annual report for 2025, with the company's operating income reaching 534 million yuan, a year-on-year increase of 14.75%. The net profit attributable to the shareholders of the listed company was 25.3821 million yuan. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 6.7923 million yuan. The basic earnings per share amounted to 0.051 yuan.